Dorsal Root Entry Zone Dose Predicts Efficacy and Toxicity for Patients Receiving a Second Radiosurgical Treatment for Recurrent Trigeminal Neuralgia
Adam Aubuchon(Wake Forest University), Edward Shaw(Wake Forest University), Michael D. Chan(Wake Forest University), Stephen B. Tatter(Atrium Health Wake Forest Baptist), J. Lovano(Wake Forest University), J. Daniel Bourland(Wake Forest University), Kevin P. McMullen(Radiation Oncology Associates), A.F. deGuzman(Wake Forest University), Thomas L. Ellis(Wake Forest University), Michael T. Munley(Radiation Oncology Associates)
International Journal of Radiation Oncology*Biology*Physics
October 5, 2009
Cited by 0
Related Papers
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05
|International Journal of Radiation Oncology*Biology*Physics|2000|1.6k
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
|Journal of Clinical Oncology|2012|1.2k
Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
|Journal of Clinical Oncology|2006|725
Radiation-induced brain injury: A review
|Frontiers in Oncology|2012|686
Subsecond dopamine fluctuations in human striatum encode superposed error signals about actual and counterfactual reward
|Proceedings of the National Academy of Sciences|2015|239